Cellosaurus BIONi010-C-13 (CVCL_RF90)
| Cell line name | BIONi010-C-13 |
|---|---|
| Synonyms | BIONi010-C + NGN2 #I7-26 |
| Accession | CVCL_RF90 |
| Resource Identification Initiative | To cite this cell line use: BIONi010-C-13 (RRID:CVCL_RF90) |
| Comments | From: Bioneer A/S; Horsholm; Denmark. Population: African. Characteristics: Expression of NEUROG2/NGN2 is doxycycline-inducible. Using TALEN NEUROG2 under the control of a tetracycline response element and a 2A-Puro was inserted into one allele of AAVS1 safe harbor locus. At the second locus a 2A-Neo-CAG-rtTA construct was inserted (PubMed=33610017). Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2. Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR. Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Transposon Tn5 neo. Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del). Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067. Cell type: Fibroblast of skin; CL=CL_0002620. |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_1E68 (BIONi010-C) |
| Sex of cell | Male |
| Age at sampling | 18Y |
| Category | Induced pluripotent stem cell |
| Publications | PubMed=33610017; DOI=10.1016/j.scr.2021.102240 |
| Cross-references | |
| Cell line collections (Providers) | EBiSC; BIONi010-C-13
ECACC; 66540561 - Discontinued |
| Cell line databases/resources | hPSCreg; BIONi010-C-13
SKIP; SKIP002903 |
| Biological sample resources | BioSamples; SAMEA103988285 |
| Encyclopedic resources | Wikidata; Q54796758 |
| Entry history | |
| Entry creation | 05-Mar-2018 |
| Last entry update | 19-Dec-2024 |
| Version number | 14 |